Blog
8 min read

Value Investing Research That Starts With Evidence

Value investing research built on filings, financial history, and management evidence can help investors estimate worth and demand a real margin of safety.

A stock can look cheap at 11 times earnings and still destroy capital. The earnings may be inflated by a temporary tax benefit. Debt may be rising faster than operating income. A respected CEO may be describing a strong customer pipeline while the company’s own filing identifies customer concentration, weakening demand, or covenant risk.

That is why value investing research cannot begin and end with a valuation multiple. Price matters, but only after the investor has established what the business earns, what it owns, what it owes, and whether management’s public story is consistent with the record.

Value Investing Research Is a Process, Not a Screen

A stock screener is useful for narrowing a large universe. It is not a conclusion. Low price-to-earnings, price-to-book, or enterprise-value-to-EBIT figures can identify businesses worth examining, but the figures do not explain why the market has set that price.

Sometimes the answer is favorable. A sound business may be temporarily unpopular after a cyclical downturn, a disappointing quarter, or an overlooked spin-off. At other times, a low multiple reflects a problem that has not yet fully appeared in the income statement: falling unit economics, a balance sheet stretched by acquisitions, a shrinking competitive position, or an incentive structure that rewards executives for growth at any cost.

The practical purpose of research is to separate those cases. A disciplined investor is not looking for a cheap-looking ticker. The investor is asking whether a dollar of business value can be purchased for materially less than a conservative estimate of its worth.

That requires a repeatable sequence: establish the economic record, test financial quality, estimate normalized earning power, assess management credibility, then compare value against price. Reversing that order invites confirmation bias. Once an investor becomes attached to a bargain price, every favorable data point can start to look more persuasive than it is.

Start With Ten Years, Not the Latest Quarter

The latest earnings release is designed to frame the latest quarter. A decade of annual reports shows the business through expansion, contraction, strategic shifts, acquisitions, and changing capital allocation decisions.

Ten years is not a magic number. Some younger businesses do not have a meaningful ten-year public record, and businesses transformed by major divestitures or mergers need separate treatment. But a long record makes recurring patterns harder to hide.

Review revenue, operating income, free cash flow, debt, share count, capital expenditures, and returns on invested capital across the period. Do not treat each line in isolation. The relationships between them carry the real signal.

For example, revenue growth accompanied by persistent growth in receivables may indicate looser customer terms or weakening collection quality. Rising earnings with flat operating cash flow deserve scrutiny. Share repurchases are not automatically shareholder-friendly if they are funded with debt or executed when the stock trades far above reasonable value. An expanding dividend is less reassuring if the payout depends on asset sales or increasingly aggressive adjustments.

The goal is not to demand a perfect record. Most good businesses face difficult years. The question is whether the business has demonstrated durable earning power, financial resilience, and an ability to recover without repeatedly asking shareholders or creditors to absorb the cost.

Normalize the Numbers Before Valuing the Business

Reported earnings are a starting point, not intrinsic value. A conservative estimate should account for items that may not recur, including unusual gains, litigation settlements, restructuring charges, impairment reversals, acquisition-related accounting, and unusually favorable commodity prices or credit conditions.

Normalization requires judgment. Treating every expense as a one-time event can make almost any company appear attractive. Treating every investment as a permanent drag can make a healthy business look worse than it is. The useful question is simple: what level of owner earnings is plausible through an ordinary business cycle, after maintaining the assets and competitive position required to produce those earnings?

For asset-light companies, maintenance capital expenditures may be modest, but stock-based compensation and working-capital needs still matter. For industrial, energy, or transportation businesses, depreciation alone may understate the cash required to maintain productive capacity. For banks and insurers, the analysis shifts toward underwriting discipline, reserve adequacy, asset quality, liquidity, and capital strength.

A single valuation formula cannot resolve those differences. The method should fit the economics of the business.

Test Quality Before You Calculate Fair Value

A valuation range is only as credible as the assumptions beneath it. Before assigning a multiple or discount rate, test the company’s ability to endure disappointment.

Start with the balance sheet. Measure debt against earnings and free cash flow, but also examine maturity schedules, interest coverage, lease obligations, pension liabilities, and off-balance-sheet commitments. Low debt is not always necessary. Stable, regulated, or contract-driven businesses can support more leverage than cyclical companies with volatile demand. Still, leverage reduces the room for error precisely when conditions worsen.

Then examine returns. High returns on capital can indicate a valuable business, but only if they are not created by excessive leverage, underinvestment, temporary scarcity, or acquisition accounting. Look for persistence. A company that earns strong returns through different conditions may possess pricing power, efficient operations, customer loyalty, or a real cost advantage.

Finally, inspect dilution and capital allocation. A business can report steady profit growth while leaving per-share owners behind. Shares issued for acquisitions, executive compensation, or employee plans change the claim each shareholder has on future earnings. Per-share progress is often more relevant than total-company growth.

Management Claims Should Be Checked Against Disclosures

Executives are paid to explain strategy with confidence. Investors are paid to distinguish confidence from evidence.

Earnings calls and interviews can be valuable because they reveal priorities, assumptions, and language patterns. Yet they should be read alongside formal disclosures, not accepted as substitutes for them. A CEO may emphasize demand strength while the 10-K expands discussion of competitive pressure. Management may characterize leverage as temporary while debt maturities move closer and free cash flow fails to improve. A company may celebrate adjusted earnings growth while the reconciliation shows recurring exclusions.

This does not mean every inconsistency is deception. Businesses are complicated, and disclosure language often becomes more cautious because legal teams require it. The issue is pattern and materiality. When optimistic claims repeatedly conflict with reported results, risk factors, insider behavior, or capital allocation decisions, an investor should demand a larger margin of safety or walk away.

This is also where filing-first research has an advantage over headline-driven commentary. Commentary often begins with a narrative and selects facts to support it. Primary documents allow the investor to trace a claim back to the reported numbers, definitions, and stated risks.

Hety applies this discipline across company filings and executive communications, translating the underlying record into valuation ranges, quality tests, and documented management-integrity findings. The output should make research faster, but the evidence should remain visible enough for an investor to challenge it.

Build a Range, Not a Precise Target

Intrinsic value is an estimate of future cash that can ultimately be taken from a business without impairing it. It is not a number that can be known to the cent.

Use a range because the future contains variables that cannot be eliminated: growth rates, margins, reinvestment needs, interest costs, competition, and management decisions. A conservative range also forces assumptions into the open. If the investment works only under a favorable case, it is not a margin-of-safety investment.

For a stable business, reasonable methods may include a normalized earnings multiple, owner earnings yield, or discounted cash flow using restrained growth assumptions. For a cyclical business, use mid-cycle margins and earnings rather than peak-year results. For asset-heavy companies, assess asset value carefully, including whether book values are realizable and whether liabilities have been fully recognized.

The appropriate discount depends on the certainty of the business. A durable company with modest debt, recurring cash generation, and proven management may justify a narrower range. A highly leveraged company, a commodity producer, or a business in structural decline requires more skepticism. Cheapness should rise with uncertainty.

Demand a Margin of Safety You Can Explain

A margin of safety is not merely buying below an analyst target. It is the gap between market price and a conservative estimate of intrinsic value, large enough to absorb ordinary analytical error and adverse business outcomes.

There is no universal percentage. A 15% discount may be meaningful for a highly predictable business with a strong balance sheet. It may be inadequate for a company facing refinancing risk, customer concentration, or a deteriorating moat. The margin should reflect the quality of the evidence, not a mechanical rule.

It also helps to write down the thesis in falsifiable terms. State what must remain true: perhaps revenue retention, debt reduction, normalized margins, or a defined level of free cash flow. Then identify what would disprove the case. This prevents a falling stock price from becoming the only reason to revisit the analysis.

Past performance is not predictive, and no research process removes investment risk. But a process built on filings, long-term financial evidence, and conservative assumptions can reduce the chance of paying for a story that the business cannot support.

Before acting on the next apparent bargain, read one annual report beyond the highlights. Find the cash flow statement, debt footnotes, share-count history, and risk factors. The best investment question is rarely “What is the market expecting next quarter?” It is “What evidence supports the value I believe I am buying?”

See the best undervalued deals on the market.

You are not going to read the balance sheet. You don’t have three hours per company to do it, and you shouldn’t have to.

Hety runs the value investor checklists you would have to run by hand, now expanded to the NYSE and Nasdaq:

  • Intrinsic value range — what the company is actually worth, not what the market says.
  • Graham tests — the same criteria Benjamin Graham used to separate real bargains from value traps.
  • A filings cross-check — what management claimed on the earnings call, verified against what they actually filed with the SEC.

No stock tips. No “hot picks.” Just the stocks where the price and reality have drifted apart — with the reasoning shown, so you can verify it yourself in minutes not hours.

See this week's most undervalued stocks — free

Free to start · no signup · no card · $29/month for the full list